IRIS
BRIGANTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.300
NA - Nord America 5.482
AS - Asia 3.585
AF - Africa 141
SA - Sud America 80
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.666
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.373
SE - Svezia 3.602
SG - Singapore 1.983
IT - Italia 1.803
RU - Federazione Russa 1.467
CN - Cina 860
FI - Finlandia 406
DE - Germania 312
IE - Irlanda 218
IN - India 194
ID - Indonesia 124
JP - Giappone 105
GB - Regno Unito 98
NL - Olanda 93
TR - Turchia 75
FR - Francia 71
CA - Canada 66
IR - Iran 60
AU - Australia 57
BR - Brasile 50
ES - Italia 47
NG - Nigeria 45
MX - Messico 32
HK - Hong Kong 26
PK - Pakistan 25
PL - Polonia 25
EG - Egitto 23
TW - Taiwan 19
BE - Belgio 17
NO - Norvegia 17
CH - Svizzera 15
GR - Grecia 15
TZ - Tanzania 13
VN - Vietnam 13
KR - Corea 12
PE - Perù 12
UA - Ucraina 12
DZ - Algeria 11
RS - Serbia 11
TH - Thailandia 11
IL - Israele 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
BD - Bangladesh 8
KE - Kenya 8
MY - Malesia 8
PH - Filippine 8
CL - Cile 7
IQ - Iraq 7
PT - Portogallo 7
EU - Europa 6
GH - Ghana 6
HR - Croazia 6
HU - Ungheria 6
LT - Lituania 6
AT - Austria 5
CM - Camerun 5
JO - Giordania 5
PG - Papua Nuova Guinea 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
CO - Colombia 4
LK - Sri Lanka 4
MA - Marocco 4
MW - Malawi 4
PA - Panama 4
TN - Tunisia 4
AM - Armenia 3
BO - Bolivia 3
GN - Guinea 3
LB - Libano 3
LV - Lettonia 3
OM - Oman 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
CU - Cuba 2
EC - Ecuador 2
GM - Gambi 2
JM - Giamaica 2
LR - Liberia 2
LU - Lussemburgo 2
MK - Macedonia 2
NP - Nepal 2
RE - Reunion 2
ZM - Zambia 2
BF - Burkina Faso 1
BJ - Benin 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
Totale 17.660
Salva come PNG Salva come JPEG
Città #
Lawrence 1.712
Princeton 1.707
Singapore 1.221
Moscow 547
Milan 449
Helsinki 389
Ashburn 315
New York 293
Shanghai 291
Dublin 214
Boardman 174
Rome 115
Pune 68
Turin 58
Los Angeles 55
Washington 43
Naples 42
Florence 40
Seattle 39
Guangzhou 38
Borås 36
Dallas 36
Beijing 28
Sydney 27
Bologna 26
Bengaluru 25
Istanbul 23
Paris 23
Pisa 23
Genoa 20
Hanover 20
Amsterdam 19
Bari 19
Makassar 19
Palermo 19
Pekanbaru 18
Santa Clara 18
Tokyo 17
Council Bluffs 16
Jakarta 16
Oldenburg 16
Central 15
Lagos 15
Rockville 15
Shenzhen 14
Chicago 13
Dar es Salaam 13
Jiaxing 13
Ankara 12
Azzano San Paolo 12
Chennai 12
Delhi 12
Hyderabad 12
Monza 12
Mumbai 12
Treviso 12
West Jordan 12
Xi'an 12
Belgrade 11
Cairo 11
Ho Chi Minh City 11
Abuja 10
Barcelona 10
Berlin 10
Cincinnati 10
Lima 10
London 10
Padova 10
Perugia 10
Semarang 10
St Petersburg 10
Bangkok 9
Bergamo 9
Brescia 9
Brussels 9
Coslada 9
Lappeenranta 9
Monterrey 9
Montreal 9
Munich 9
Parma 9
Pavia 9
Quanzhou 9
Redwood City 9
San Jose 9
São Paulo 9
Tehran 9
Athens 8
Brisbane 8
Hangzhou 8
Karachi 8
Perth 8
Vaprio d'Adda 8
Wuxi 8
Brooklyn 7
Bursa 7
Kaohsiung City 7
Katsina 7
Kebumen Satu 7
Kolkata 7
Totale 8.867
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 879
Benign Prostatic Hyperplasia and Its Aetiologies 377
Women's sexual dysfunction: a pathophysiological review 233
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 101
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 92
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 79
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 62
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 60
Prediction of Sexual Function After Radical Prostatectomy 59
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 53
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 52
A propensity score approach for treatment evaluation based on Bayesian Networks 52
FATTORI PREDITTIVI DI LINFORREA DOPO PROSTATECTOMIA RADICALE E LINFOADENECTOMIA PELVICA 49
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 47
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 46
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 44
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 43
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 42
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 41
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 40
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 40
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 39
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 37
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 36
Pelvic lymph node dissection in prostate cancer 36
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 35
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 34
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 34
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 33
QUALI SONO I PAZIENTI A RISCHIO DI RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO OLTRE I 10 ANNI DI FOLLOW-UP DOPO PROSTATECTOMIA RADICALE? 33
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 33
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 32
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 31
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 31
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 31
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 30
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 30
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 30
Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy 29
Radical prostatectomy for incidental (stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence 29
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 29
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 29
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 29
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 28
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 28
ELETTROSTIMOLAZIONE INTRAOPERATORIA DEI NERVI CAVERNOSI CON ELETTRODI IMPIANTABILI 28
PRESENTAZIONE CLINICA DELLA INDURATIO PENIS PLASTICA NEI PAZIENTI AL DI SOTTO DEI 40 ANNI 28
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 28
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 28
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 27
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 27
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 27
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 27
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 27
How to Select the Optimal Candidates for Renal Mass Biopsy 27
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 26
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial 26
Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer 26
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 26
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 25
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 25
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 25
PICCOLE MASSE RENALI: SORVEGLIANZA ATTIVA VS. NEFRECTOMIA 25
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 25
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 25
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 25
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 25
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 25
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 25
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 24
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 24
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 24
L'INVASIONE ESCLUSIVA DEL COLLO VESCICALE DA CARCINOMA PROSTATICO NON DOVREBBE ESSERE CONSIDERATA COME STADIO PT4 24
Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience 24
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 24
A risk calculator predicting recurrence in lymph node metastatic penile cancer 24
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 24
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 24
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 24
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 23
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 23
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 23
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 23
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 23
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 23
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 22
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 22
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 22
External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection 22
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 22
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 22
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 22
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 22
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 22
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 22
Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection 21
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 21
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 21
Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy 21
Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer 21
Totale 4.588
Salva come PNG Salva come JPEG
Categoria #
all - tutte 377.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 377.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 0 28 3 0 1 5 2 0 0
2020/2021267 0 1 18 3 5 205 4 1 21 6 3 0
2021/20221.070 0 46 34 465 59 58 95 67 33 60 43 110
2022/20238.186 3.963 1.456 485 71 52 806 299 458 256 84 137 119
2023/20243.873 149 212 329 296 296 576 217 374 84 317 466 557
2024/20254.759 3.055 567 362 532 243 0 0 0 0 0 0 0
Totale 18.651